Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Sets New 52-Week High – What’s Next?

Shares of Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $11.34 and last traded at $11.04, with a volume of 134744 shares changing hands. The stock had previously closed at $10.97.

Analyst Upgrades and Downgrades

Separately, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Fresenius SE & Co. KGaA in a research note on Monday, February 3rd.

Fresenius SE & Co. KGaA Stock Performance

The company’s 50-day moving average price is $10.45 and its two-hundred day moving average price is $9.56. The stock has a market cap of $24.82 billion, a PE ratio of 52.90 and a beta of 0.86. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.05 and a current ratio of 1.36.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.18 earnings per share (EPS) for the quarter. The business had revenue of $6.01 billion for the quarter. On average, equities research analysts forecast that Fresenius SE & Co. KGaA will post 0.79 EPS for the current year.

Fresenius SE & Co. KGaA Company Profile

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.